Clinical Trial Update: Evaluation of the Next Generation WATCHMAN LAA Closure Technology in Non-Valvular AF Patients (EVOLVE) [NA]

View source ↗

Summary

A completed clinical trial evaluating the next-generation WATCHMAN left atrial appendage closure system for non-valvular atrial fibrillation.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Atrial Fibrillation

Snippet

Sponsor: Boston Scientific Corporation | Conditions: Atrial Fibrillation | NA | Status: COMPLETED